GE HealthCare Technologies closed at $85.81 on Nov 4, up 6.38%, 2.7% below its 52-week closing high. Volume of 9.6M shares was 2.40× its 20-day average (well above normal).
Split-adjusted performance: +32.5% over one month, +39.0% over six months, +15.2% over one year.
In the quarter ended Sep 30, 2026, revenue was $5.51B, up 7.2% from a year earlier, with a net margin of 11.2%.
Short interest was 19.4M shares at the Oct 15 settlement, up 4.6% from the prior report (4.3% of float, 5.1 days to cover).